Characteristic | Group | P value | |
Liraglutide (n = 34) | Dulaglutide (n = 20) | ||
Age (years) | 57 (41 - 61) | 60 (54 - 63) | 0.113 |
Sex: Male: Female: |
8 (23.5%) 26 (76.5%) |
8 (40%) 12 (60%) | 0.201 |
Weight (kg) | 102.6 ± 18.3 | 100 ± 20.6 | 0.319 |
BMI (kg/m2) | 39 ± 6.3 | 38.8 ± 6.9 | 0.402 |
SBP (mmHg) | 127.8 ± 13.3 | 127.4 ± 20.1 | 0.934 |
DBP (mmHg) | 75.6 ± 7.8 | 74 ± 8.6 | 0.467 |
Pulse (bpm) | 81.9 ± 11.3 | 86.5 ± 14 | 0.198 |
FPG (mmol/L) | 10.8 ± 3.9 | 12.8 ± 4.9 | 0.281 |
HbA1C % | 8.5 ± 1.6 | 8.6 ± 1.8 | 0.821 |
Serum Cr (mmol/L) | 78.3 ± 23.5 | 79.8 ± 17.6 | 0.857 |
eGFR (ml/min/1.73m2) | 116 (96 - 150) | 103.7 (85.8 - 127) | 0.352 |
BUN (mmol/L) | 5.8 ± 2.2 | 8.1 ± 3.9 | 0.217 |
ACR (mg/gm) | 9.4 (5.5 - 39.4) | 9.2 (8.5 - 20.4) | 0.765 |
T-C (mmol/L) | 4.3 ± 0.9 | 4.4 ± 1.97 | 0.946 |
LDL-C (mmol/L) | 2.4 ± 0.85 | 2.8 ± 1.46 | 0.616 |
HDL-C (mmol/L) | 1.3 ± 0.3 | 1.4 ± 0.3 | 0.638 |
TG (mmol/L) | 1.5 ± 0.6 | 1.6 ± 0.98 | 0.872 |